http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017276253-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 |
| filingDate | 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b0dec2aef32c68121d2d810e193acd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556748843d26b1f6693353a0f9e8d7a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c7a16f619968af7c285c6eadc4e01e |
| publicationDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2017276253-A1 |
| titleOfInvention | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
| abstract | I:\grs\Interwovn\NRPortbl\DCC\GRS\16165661_1.docx-13 12/2017 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3 DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES Abstract The present invention relates to pharmaceutical compositions, containing 4-[1 (2,3-dimethylphenyl)ethyl]-1 H-imidazole, (S) 4-[1 -(2,3-dimethylphenyl)ethyl]-1 H imidazole or (S) [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol, their use as pharmaceuticals for the treatment of retinal diseases, for retinal neuroprotection and vision enhancement. WO 2013/078151 PCT/US2012/065942 0 5 No BL E E * ** * Vehicle/BL (S) [3-(1 -(1 H-im idazol-4-yl)ethyl)-2-methylphenyl] 0.20 methanol-BL inferior superior inferior superior |
| priorityDate | 2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.